Arbutus Biopharma Corp

NASDAQ:ABUS   3:59:59 PM EDT
1.97
-0.07 (-3.43%)
Products

Arbutus Biopharma Announces Issuance Of New U.S. Patent Related To AB-729

Published: 08/30/2022 11:55 GMT
Arbutus Biopharma Corp (ABUS) - Arbutus Biopharma Announces Issuance of a New Key U.S. Patent Related to Ab-729.
Arbutus Biopharma Corp - Patent is Expected to Provide Arbutus With Exclusivity for Ab-729 Out to at Least April 2038.